Jae-Sam Lee

Title: Innovations by Jae-Sam Lee in Biopharmaceutical Growth Factors

Introduction

Jae-Sam Lee is an accomplished inventor based in Houston, TX (US). She has made significant contributions to the field of biopharmaceuticals, particularly in the area of controlled release mechanisms for growth factors. Her innovative work has the potential to enhance surgical outcomes in ligament reconstruction procedures.

Latest Patents

Jae-Sam Lee holds a patent for the "Controlled release of biopharmaceutical growth factors from hydroxyapatite coating on bioresorbable interference screws used in cruciate ligament reconstruction surgery." This invention focuses on biologically active scaffolds, such as interference bone screws, which are essential for ligament fixation. The patent describes a method of growing calcium phosphate-based hydroxyapatite coatings on bioresorbable poly(α-hydroxy ester) scaffolds. This method allows for controlled mineral dissolution and the release of bone morphogenetic protein-2 (BMP-2), which is crucial for enhancing graft-bone healing in the tibial bone tunnel.

Career Highlights

Jae-Sam Lee is associated with the Wisconsin Alumni Research Foundation, where she continues to advance her research and innovations. Her work emphasizes the importance of bioavailability in growth factors, which can significantly improve healing processes in surgical applications.

Collaborations

Some of her notable coworkers include William Leo Murphy and Mark D Markel, who have collaborated with her on various projects related to biopharmaceutical innovations.

Conclusion

Jae-Sam Lee's contributions to the field of biopharmaceutical growth factors represent a significant advancement in medical technology. Her innovative approaches have the potential to improve surgical outcomes and enhance patient recovery.